HK1007503A1 - Ophthalmic composition containing timolol hemihydrate - Google Patents

Ophthalmic composition containing timolol hemihydrate Download PDF

Info

Publication number
HK1007503A1
HK1007503A1 HK98106760A HK98106760A HK1007503A1 HK 1007503 A1 HK1007503 A1 HK 1007503A1 HK 98106760 A HK98106760 A HK 98106760A HK 98106760 A HK98106760 A HK 98106760A HK 1007503 A1 HK1007503 A1 HK 1007503A1
Authority
HK
Hong Kong
Prior art keywords
ophthalmic composition
composition according
ophthalmic
adjuvants
morpholino
Prior art date
Application number
HK98106760A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1007503B (en
Inventor
Peralampi Markku
Lehmussaari Kari
Oksala Olli
Pohjala Esko
Reunamaki Timo
Ruohonen Jarkko
Original Assignee
Santen Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co., Ltd. filed Critical Santen Pharmaceutical Co., Ltd.
Publication of HK1007503B publication Critical patent/HK1007503B/en
Publication of HK1007503A1 publication Critical patent/HK1007503A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HK98106760A 1992-07-08 1998-06-25 Ophthalmic composition containing timolol hemihydrate HK1007503A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91066592A 1992-07-08 1992-07-08
US910665 1992-07-08

Publications (2)

Publication Number Publication Date
HK1007503B HK1007503B (en) 1999-04-16
HK1007503A1 true HK1007503A1 (en) 1999-04-16

Family

ID=25429138

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106760A HK1007503A1 (en) 1992-07-08 1998-06-25 Ophthalmic composition containing timolol hemihydrate

Country Status (21)

Country Link
EP (1) EP0577913B1 (cs)
JP (1) JP3094233B2 (cs)
KR (1) KR100278851B1 (cs)
AT (1) ATE154513T1 (cs)
AU (1) AU678972B2 (cs)
BR (1) BR9306800A (cs)
CA (1) CA2139781C (cs)
CZ (1) CZ282168B6 (cs)
DE (1) DE69220484T2 (cs)
DK (1) DK0577913T3 (cs)
EE (1) EE03078B1 (cs)
ES (1) ES2106852T3 (cs)
FI (1) FI112321B (cs)
GR (1) GR3024648T3 (cs)
HK (1) HK1007503A1 (cs)
HU (1) HU221618B1 (cs)
NO (1) NO306535B1 (cs)
NZ (1) NZ253164A (cs)
PL (1) PL172503B1 (cs)
SG (1) SG49770A1 (cs)
WO (1) WO1994001115A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451799B1 (en) 1996-10-28 2002-09-17 Senju Pharmaceutical Co., Ltd. Drugs for ameliorating ocular circulatory disorders
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
WO2004098592A1 (ja) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. オキサゾリジノン誘導体含有組成物
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
JP2014024794A (ja) * 2012-07-27 2014-02-06 Nippon Tenganyaku Kenkyusho:Kk チモロールまたはその薬学的に許容される塩を含有する水性組成物およびその光安定化方法
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195085A (en) 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
FI82240C (fi) 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.

Also Published As

Publication number Publication date
DK0577913T3 (da) 1998-01-26
FI950050A0 (fi) 1995-01-04
KR100278851B1 (ko) 2001-01-15
NO306535B1 (no) 1999-11-22
GR3024648T3 (en) 1997-12-31
JPH07508745A (ja) 1995-09-28
KR950702422A (ko) 1995-07-29
CZ4495A3 (en) 1995-09-13
HUT72657A (en) 1996-05-28
ES2106852T3 (es) 1997-11-16
AU678972B2 (en) 1997-06-19
NO950059D0 (no) 1995-01-06
CA2139781C (en) 2003-09-23
EP0577913A1 (en) 1994-01-12
WO1994001115A1 (en) 1994-01-20
DE69220484T2 (de) 1998-02-05
SG49770A1 (en) 1998-06-15
PL172503B1 (pl) 1997-10-31
BR9306800A (pt) 1998-12-08
ATE154513T1 (de) 1997-07-15
CA2139781A1 (en) 1994-01-20
DE69220484D1 (de) 1997-07-24
NO950059L (no) 1995-01-06
CZ282168B6 (cs) 1997-05-14
EE03078B1 (et) 1998-04-15
FI112321B (fi) 2003-11-28
HU9500035D0 (en) 1995-03-28
JP3094233B2 (ja) 2000-10-03
HU221618B1 (hu) 2002-12-28
AU4329693A (en) 1994-01-31
NZ253164A (en) 1996-01-26
FI950050L (fi) 1995-01-04
EP0577913B1 (en) 1997-06-18
PL307051A1 (en) 1995-05-02

Similar Documents

Publication Publication Date Title
US7402609B2 (en) Olopatadine formulations for topical administration
US5710182A (en) Ophthalmic composition
EP0755246B1 (en) Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
AU2002310461A1 (en) Olopatadine formulations for topical administation
US5767143A (en) Ophthalmological preparation
EP0577913B1 (en) Ophthalmic composition containing timolol hemihydrate
HK1007503B (en) Ophthalmic composition containing timolol hemihydrate
RU2100020C1 (ru) Средство для местного лечения глазной гипертензии и глаукомы и способ его получения
EP0140789B1 (en) Use of peripherally selective dopamine antagonists for the preparation of a medicament for the topical treatment of ocular hypertension
US5496820A (en) Ophthalmic use of S-timolol hemihydrate
KR101185612B1 (ko) 피페라진 유도체의 약제 조성물
HK1013955B (en) Ophthalmological preparation
HK1059573B (en) Olopatadine formulations for topical administration
EP0375319A2 (en) Angiotensin converting enzyme inhibitors in the treatment of glaucoma
HK1013953B (en) Ophthalmic composition with decreased viscosity

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20051216